Skip to main content
SpringerLink
Log in

Does agomelatine block 5-HT2C receptors in humans?

  • letter to editor
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Attenburrow MEJ, Cowen PJ, Sharpley AL (1996) Low dose melatonin improves sleep in healthy middle-aged subjects. Psychopharmacol 126:179–181

    Article  CAS  Google Scholar 

  • Aslan S, Isik E, Cosar B (2002) The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers. Sleep 25:677–679

    PubMed  Google Scholar 

  • Dolder CR, Nelson M, Snider M (2008) Agomelatine treatment of major depressive disorder. Ann Pharmacother 42:1822–1831

    Article  CAS  PubMed  Google Scholar 

  • Leproult R, Van Onderbergen A, L’Hermite-Balériaux M, Van Cauter E, Copinschi G (2005) Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. Clin Endocrinol 63:298–304

    Article  CAS  Google Scholar 

  • Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman-Tancredi A, Pasteau V, Rivet J-M, Cussac D (2003) The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther 306:954–964

    Article  CAS  PubMed  Google Scholar 

  • Quera Salva M-A, Vanier B, Laredo J, Hartley S, Chapotot F, Moulin C, Lofaso F, Guilleminault C (2007) Major depressive disorder, sleep EEG and agomelatine: an open label study. Int J Neuropsychopharmacol 10:691–696

    CAS  PubMed  Google Scholar 

  • Seibyl JP, Krystal JH, Price LH, Woods SW, D’Amico C, Heninger GR, Charney DS (1991) Effects of ritanserin on the behavioral, neuroendocrine and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects. Psychiat Res 38:227–236

    Article  CAS  Google Scholar 

  • Sharpley AL, Cowen PJ (1995) Effect of pharmacologic treatments on the sleep of depressed patients. Biol Psychiatry 37:85–98

    Article  CAS  PubMed  Google Scholar 

  • Sharpley AL, Elliott JM, Attenburrow M-J, Cowen PJ (1994) Slow wave sleep in humans: Role of 5-HT2A and 5-HT2C receptors. Neuropharmacology 33:467–471

    Article  CAS  PubMed  Google Scholar 

  • Sharpley AL, Vassallo CM, Cowen PJ (2000) Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT2C receptors in vivo. Biol Psychiatry 47:468–470

    Article  CAS  PubMed  Google Scholar 

  • Solomon RA, Sharpley AL, Cowen PJ (1989) Increased slow wave sleep with 5-HT2 receptor antagonists: detection by ambulatory EEG recording and automatic sleep stage analysis. J Psychopharmacol 3:125–129

    Article  CAS  Google Scholar 

Download references

Acknowledgement

PJC has served as a paid member of an advisory board for Servier who market agomelatine. Servier played no role in the funding, design, or analysis of the study.

Author information

Authors and Affiliations

  1. University Department of Psychiatry, Neurosciences Building, Warneford Hospital, Oxford, OX3 7JX, UK

    Ann L. Sharpley, Nancy B. Rawlings, Susannah Brain, Sarah F. B. McTavish & Philip J. Cowen

Authors
  1. Ann L. Sharpley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nancy B. Rawlings
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susannah Brain
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sarah F. B. McTavish
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Philip J. Cowen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philip J. Cowen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharpley, A.L., Rawlings, N.B., Brain, S. et al. Does agomelatine block 5-HT2C receptors in humans?. Psychopharmacology 213, 653–655 (2011). https://doi.org/10.1007/s00213-010-1993-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-010-1993-6

Keywords

Search

Navigation